Position in CBLL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$492,687
+$308,086 QoQ
Shares Held
25,331
+151.5% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 123 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CBLL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $3,522,935,622 across 102 Medical Devices names. CBLL ranks #51 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
15,177,317 | $1,377,189,742 | |
| 2 | SYK |
Stryker Corp
|
2,407,680 | $758,033,968 | |
| 3 | MDT |
Medtronic plc
|
7,904,930 | $618,402,670 | |
| 4 | BSX |
Boston Scientific Corp
|
3,051,613 | $130,242,842 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,041,675 | $94,229,919 | |
| 6 | GMED |
Globus Medical Inc
|
996,617 | $78,742,707 | |
| 7 | DXCM |
Dexcom Inc
|
1,011,869 | $68,149,375 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
879,516 | $56,297,816 |
All Filings in CBLL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $492,687 | 25,331 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $184,601 | 10,071 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $643,754 | 29,355 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $178,163 | 15,506 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $244,968 | 13,079 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $126,305 | 6,575 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $166,511 | 6,434 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||